Gina Kim
About Gina Kim
Gina Kim is an Associate at Arnold & Porter Kaye Scholer LLP in New York, specializing in intellectual property law and representing clients in the life sciences sector. She holds multiple advanced degrees, including a Master of Laws from Cardozo School of Law and a Master of Science from The University of Edinburgh.
Work at Arnold & Porter
Gina Kim has been an Associate at Arnold & Porter Kaye Scholer LLP since 2022. In her role, she represents clients in the life sciences sector, including major pharmaceutical companies and early-stage biotech firms. She handles a variety of transactional and licensing matters, focusing on intellectual property and technology issues. Her responsibilities include leading due diligence processes and supervising junior associates in drafting both general and IP-focused diligence reports.
Education and Expertise
Gina Kim holds a Master of Laws (LLM) in Intellectual Property Law from Cardozo School of Law, which she completed in 2018. She also earned a Doctor of Law (J.D.) from Fordham University School of Law in 2016. Additionally, she has a Master of Science (MSc) in Quantitative Genetics from The University of Edinburgh, obtained in 2011, and a Bachelor of Science (BSc) in Biology from Ewha Womans University, completed in 2010. In 2020, she furthered her education with an HMX Pro Online Certificate in Cancer Genomics from Harvard Medical School.
Background
Gina Kim has a diverse professional background, having worked in various legal roles prior to her current position. She served as an Associate at Hodgson Russ LLP from 2020 to 2022 and at Leason Ellis LLP from 2018 to 2019. Her earlier experience includes positions as a Legal Extern at Nielsen and Lucas & Mercanti LLP, and as a Judicial Intern with the New York State Unified Court System. She also gained international experience as a Legal Intern with Yulchon LLC in South Korea and as a Legal Intern with the US Army in Korea.
Achievements
In her legal career, Gina Kim has specialized in drafting and negotiating complex agreements related to intellectual property, technology, and commercial transactions. She has provided expertise in evaluating intellectual property and technology issues during mergers and acquisitions, focusing on ownership, assignment, and validity. Her role involves representing clients in matters concerning biologics, small molecule drugs, and medical devices.